Bharat Biotech's COVID-19 Nasal Vaccine Approved By Indian Govt For Use in Adults in Emergency Situations

Bharat Biotech's intranasal COVID-19 vaccine candidate, BBV-154, has been approved by the Drugs Controller General of India (DCGI), on Tuesday. This is the world's first intra-nasal COVID-19 vaccine.

Check Tweet:

This step will further strengthen our collective fight against the pandemic.

India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji's leadership.

With the science-driven approach & Sabka Prayas, we will defeat COVID-19.

— Dr Mansukh Mandaviya (@mansukhmandviya) September 6, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)